COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,170 Articles (22,186 medRxiv, 7,984 bioRxiv)

Most recent first Previous |  Page 1463: Articles 14621-14630  | Next

U.S. Regional Differences in Physical Distancing: Evaluating Racial and Socioeconomic Divides During the COVID-19 Pandemic
Zang, E., West, J., Kim, N., Pao, C.
10.1101/2021.04.27.21256210 — Posted: 2021-04-30
The causal effects of chronic air pollution on the intensity of COVID-19 disease: Some answers are blowing in the wind
Conte, M. N., Gordon, M., Swartwood, N., Wilwerding, R., Yu, C. A.
10.1101/2021.04.28.21256146 — Posted: 2021-04-30
COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
Longchamps, C., Ducarroz, S., Crouzet, L., Vignier, N., Pourtau, L., Allaire, C., Colleville, A.-C., El Aarbaoui, T., Melchior, M.
10.1101/2021.04.29.21256256 — Posted: 2021-04-30
SARS-CoV-2 Vaccination Uptake in a Correctional Setting
Berk, J., Murphy, M., Chan, P., Kane, K., Rich, J., Brinkley-Rubinstein, L.
10.1101/2021.04.27.21252790 — Posted: 2021-04-29
Clinical Risk, Sociodemographic Factors, and SARS-CoV-2 Infection Over Time in Ontario, Canada
Udell, J. A., Behrouzi, B., Sivaswamy, A., Chu, A., Ferreira-Legere, L. E., Fang, J., Goodman, S. G., Ezekowitz, J. A., Bainey, K. R., van Diepen, S., Kaul, P., McAlister, F. A., Bogoch, I., Jackevicius, C., Abdel-qadir, H., Wijeysundera, H. C., Ko, D. T., Austin, P. C., Lee, D. S.
10.1101/2021.04.28.21256052 — Posted: 2021-04-29
From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
Radon, K., Bakuli, A., Puetz, P., Le Gleut, R., Guggenbuehl Noller, J. M., Olbrich, L., Saathoff, E., Gari, M., Schaelte, Y., Frahnow, T., Woelfel, R., Pritsch, M., Rothe, C., Pletschette, M., Rubio-Acero, R., Beyerl, J., Metaxa, D., Forster, F., Thiel, V., Castelletti, N., Riess, F., Diefenbach, M. N., Froeschl, G., Bruger, J. M., Winter, S. M., Frese, J. L., Puchinger, K., Brand, I., Kroidl, I., Wieser, A., Hoelscher, M., Hasenauer, J., Fuchs, C., KoCo19 study group
10.1101/2021.04.27.21256133 — Posted: 2021-04-29
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020.
George, J. A., Khoza, S., Mayne, E., Dlamini, S., Kone, N., Jassat, W., Chetty, K., Centner, C., Pillay, T., Maphayi, M. R., Mabuza, D. V., Maposa, I. A., Cassim, N.
10.1101/2021.04.27.21256099 — Posted: 2021-04-29
Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein
Mallm, J.-P., Bundschuh, C., Kim, H., Weidner, N., Steiger, S., Lander, I., Börner, K., Bauer, K., Hübschmann, D., Benes, V., Rausch, T., Trevisan Doimo de Azevedo, N., Telzerow, A., Jost, K. L., Parthe, S., Schnitzler, P., Boutros, M., Müller, B., Bartenschlager, R., Kräusslich, H.-G., Rippe, K.
10.1101/2021.04.27.21254849 — Posted: 2021-04-29
Impairment of T cells' antiviral and anti-inflammation immunities dominates the death from COVID-19
She, Z.-s., Scholes, G., Zhang, L., Li, R., Song, G.
10.1101/2021.04.26.21256093 — Posted: 2021-04-29
Host-pathogen dynamics in longitudinal clinical specimens from patients with COVID-19
Lin, M. J., Rachleff, V. M., Xie, H. J., Shrestha, L., Lieberman, N. A., Peddu, V., Addetia, A., Casto, A., Breit, N., Mathias, P. C., Huang, M., Jerome, K., Greninger, A. L., Roychoudhury, P.
10.1101/2021.04.27.21256149 — Posted: 2021-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).